Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 477


Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.

Schuler M, Tretter T, Schneller F, Huber C, Peschel C.

Immunobiology. 1999 Feb;200(1):128-39.


Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.

Tretter T, Schuler M, Schneller F, Brass U, Esswein M, Aman MJ, Huber C, Peschel C.

Cell Immunol. 1998 Oct 10;189(1):41-50.


Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.

Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T.

Blood. 1992 Dec 15;80(12):3173-81.


In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.

Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, Leis J, Maziarz RT, Tiberghien P, Berenson RJ.

J Immunol. 2005 Feb 15;174(4):2366-75.


Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.

Decker T, Flohr T, Trautmann P, Aman MJ, Holter W, Majdic O, Huber C, Peschel C.

Blood. 1995 Aug 1;86(3):1115-23.


Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.

Hoehn P, Goedert S, Germann T, Koelsch S, Jin S, Palm N, Ruede E, Schmitt E.

J Immunol. 1995 Oct 15;155(8):3788-93.


Role of IL-13 in CD4 T cell-dependent IgE production in atopy.

Levy F, Kristofic C, Heusser C, Brinkmann V.

Int Arch Allergy Immunol. 1997 Jan;112(1):49-58.


Human germinal center CD4+CD57+ T cells act differently on B cells than do classical T-helper cells.

Bouzahzah F, Bosseloir A, Heinen E, Simar LJ.

Dev Immunol. 1995;4(3):189-97.


Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.

Schattner EJ, Mascarenhas J, Reyfman I, Koshy M, Woo C, Friedman SM, Crow MK.

Blood. 1998 Apr 15;91(8):2689-97.


Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.

Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R.

Blood. 1996 May 15;87(10):4382-9.


Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F, Ruffing N, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F.

Eur J Immunol. 2002 May;32(5):1403-13.


IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.

Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J.

Immunology. 1994 Nov;83(3):397-403.


Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.

Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS.

Blood. 1997 Feb 1;89(3):941-7.


Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.

Tiemessen MM, Kunzmann S, Schmidt-Weber CB, Garssen J, Bruijnzeel-Koomen CA, Knol EF, van Hoffen E.

Int Immunol. 2003 Dec;15(12):1495-504.


Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.

Wallgren A, Festin R, Gidlöf C, Dohlsten M, Kalland T, Tötterman TH.

Blood. 1993 Aug 15;82(4):1230-8.

Supplemental Content

Support Center